Kynda enables its customers to produce mycelium in-house using low-cost plug & play bioreactors, starter cultures and operational support.
Kynda has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Kynda's investors include FoodLabs, better ventures, Enjoyventure Management, Shio Capital, Twin Peaks Capital.
Kynda is headquartered in Jelmstorf, Germany.
Kynda enables its customers to produce mycelium in-house using low-cost plug & play bioreactors, starter cultures and operational support.
Kynda is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kynda — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/kynda. Accessed July 25, 2026.
VCBacked. (2025). Kynda — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/kynda
{{cite web |title=Kynda — Funding & Investors |url=https://www.vcbacked.co/company/kynda |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated